 direct effect hyperinsulinemia serum sex hormone-bind globulin level obes women polycyst ovari syndrom hyperinsulinemia sex hormone-bind globulin shbg level obes women polycyst ovari syndrom obes women disord studi ovarian steroid product woman administr mg long-act gnrh agonist leuprolid depot im day substanti reduct serum concentr testosteron nmol/l day nmol/l day non-shbg-bound testosteron pmol/l day pmol/l day nmol/l day nmol/l day pmol/l day pmol/l day pmol/l day pmol/l day progesteron nmol/l day nmol/l day serum shbg level chang nmol/l day nmol/l day leuprolid treatment women oral diazoxid mg/day day serum insulin level diazoxid treatment suppress insulin releas oral glucos toler test insulin area curv nmol/min.l day nmol/min.l day deterior glucos toler serum testosteron androstenedion estron estradiol progesteron level combin diazoxid leuprolid treatment contrast shbg level nmol/l day nmol/l day due rise serum shbg level non-shbg-bound testosteron level pmol/l day pmol/l day observ hyperinsulinemia serum shbg level obes women polycyst ovari syndrom effect serum sex steroid